160 related articles for article (PubMed ID: 20614571)
1. The effects of preloading infusion with hydroxyethyl starch 200/0.5 or 130/0.4 solution on hypercoagulability and excessive platelet activation of patients with colon cancer.
Liang H; Yang CX; Li H; Wen XJ; Zhou QL; Gu MN
Blood Coagul Fibrinolysis; 2010 Jul; 21(5):406-13. PubMed ID: 20614571
[TBL] [Abstract][Full Text] [Related]
2. The effect of hydroxyethyl starch 200 kD on platelet function.
Stögermüller B; Stark J; Willschke H; Felfernig M; Hoerauf K; Kozek-Langenecker SA
Anesth Analg; 2000 Oct; 91(4):823-7. PubMed ID: 11004032
[TBL] [Abstract][Full Text] [Related]
3. Effect of the carrier solution for hydroxyethyl starch on platelet aggregation and clot formation.
Schaden E; Wetzel L; Kozek-Langenecker S; Thaler U; Scharbert G
Br J Anaesth; 2012 Oct; 109(4):572-7. PubMed ID: 22791802
[TBL] [Abstract][Full Text] [Related]
4. Compromised blood coagulation: an in vitro comparison of hydroxyethyl starch 130/0.4 and hydroxyethyl starch 200/0.5 using thrombelastography.
Jamnicki M; Zollinger A; Seifert B; Popovic D; Pasch T; Spahn DR
Anesth Analg; 1998 Nov; 87(5):989-93. PubMed ID: 9806670
[TBL] [Abstract][Full Text] [Related]
5. The effects of hydroxyethyl starch solutions on thromboelastography in preoperative male patients.
Felfernig M; Franz A; Bräunlich P; Fohringer C; Kozek-Langenecker SA
Acta Anaesthesiol Scand; 2003 Jan; 47(1):70-3. PubMed ID: 12492800
[TBL] [Abstract][Full Text] [Related]
6. [Effects of preoperative acute hypervolemic hemodilution on hypercoagulability of patients with colon cancer].
Liang H; Yang CX; Li H; Liu HZ; Wang HB
Ai Zheng; 2006 Oct; 25(10):1256-60. PubMed ID: 17059771
[TBL] [Abstract][Full Text] [Related]
7. Effects of a new modified, balanced hydroxyethyl starch preparation (Hextend) on measures of coagulation.
Boldt J; Haisch G; Suttner S; Kumle B; Schellhaass A
Br J Anaesth; 2002 Nov; 89(5):722-8. PubMed ID: 12393770
[TBL] [Abstract][Full Text] [Related]
8. The influence of intravascular volume therapy with a new hydroxyethyl starch preparation (6% HES 130/0.4) on coagulation in patients undergoing major abdominal surgery.
Haisch G; Boldt J; Krebs C; Kumle B; Suttner S; Schulz A
Anesth Analg; 2001 Mar; 92(3):565-71. PubMed ID: 11226079
[TBL] [Abstract][Full Text] [Related]
9. Hemostatic changes in patients receiving hydroxyethyl starch: the influence of ABO blood group.
Huraux C; Ankri A A; Eyraud D; Sevin O; Ménégaux F; Coriat P; Samama CM
Anesth Analg; 2001 Jun; 92(6):1396-401. PubMed ID: 11375811
[TBL] [Abstract][Full Text] [Related]
10. The effects of hydroxyethyl starches of varying molecular weights on platelet function.
Franz A; Bräunlich P; Gamsjäger T; Felfernig M; Gustorff B; Kozek-Langenecker SA
Anesth Analg; 2001 Jun; 92(6):1402-7. PubMed ID: 11375812
[TBL] [Abstract][Full Text] [Related]
11. Effects of colloid pre-loading on thromboelastography during elective intracranial tumor surgery in pediatric patients: hydroxyethyl starch 130/0.4 versus 5% human albumin.
Peng Y; Du J; Zhao X; Shi X; Wang Y
BMC Anesthesiol; 2017 Apr; 17(1):62. PubMed ID: 28449710
[TBL] [Abstract][Full Text] [Related]
12. Hydroxyethyl starch 200/0.5 decreases circulating tumor cells of colorectal cancer patients and reduces metastatic potential of colon cancer cell line through inhibiting platelets activation.
Liang H; Yang C; Zhang B; Wang H; Liu H; Zhao Z; Zhang Z; Wen X; Lai X
Med Oncol; 2015 May; 32(5):151. PubMed ID: 25832864
[TBL] [Abstract][Full Text] [Related]
13. Hydroxyethyl starch (HES) 130/0.4 provides larger and faster increases in tissue oxygen tension in comparison with prehemodilution values than HES 70/0.5 or HES 200/0.5 in volunteers undergoing acute normovolemic hemodilution.
Standl T; Burmeister MA; Schroeder F; Currlin E; Schulte Esch J; Freitag M; Schulte Esch J
Anesth Analg; 2003 Apr; 96(4):936-943. PubMed ID: 12651637
[TBL] [Abstract][Full Text] [Related]
14. The impact of 30 ml/kg hydroxyethyl starch 130/0.4 vs hydroxyethyl starch 130/0.42 on coagulation in patients undergoing abdominal surgery.
Staikou C; Paraskeva A; Fassoulaki A
Indian J Med Res; 2012 Sep; 136(3):445-50. PubMed ID: 23041738
[TBL] [Abstract][Full Text] [Related]
15. Differential platelet receptor expression following hydroxyethyl starch infusion in thrombocytopaenic orthotopic liver transplantation recipients.
Jüttner B; Kuse ER; Elsner HA; Heine J; Jaeger K; Piepenbrock S; Scheinichen D
Eur J Anaesthesiol; 2004 Apr; 21(4):309-13. PubMed ID: 15109195
[TBL] [Abstract][Full Text] [Related]
16. Effects of two different hydroxyethyl starch solutions (HES200/0.5 vs. HES130/0.4) on the expression of platelet membrane glycoprotein.
Chen G; Yan M; Lu QH; Gong M
Acta Anaesthesiol Scand; 2006 Oct; 50(9):1089-94. PubMed ID: 16987338
[TBL] [Abstract][Full Text] [Related]
17. In vivo investigation into the effects of haemodilution with hydroxyethyl starch (200/0.5) and normal saline on coagulation.
Ruttmann TG; James MF; Aronson I
Br J Anaesth; 1998 May; 80(5):612-6. PubMed ID: 9691864
[TBL] [Abstract][Full Text] [Related]
18. The effects of haemodilution with hydroxyethyl starch 130/0.4 solution on coagulation as assessed by thromboelastography and platelet receptor function studies in vitro.
Williams P; Yang K; Kershaw G; Wong G; Dunkley S; Kam PC
Anaesth Intensive Care; 2015 Nov; 43(6):734-9. PubMed ID: 26603798
[TBL] [Abstract][Full Text] [Related]
19. Coagulation effects of a recently developed hydroxyethyl starch (HES 130/0.4) compared to hydroxyethyl starches with higher molecular weight.
Entholzner EK; Mielke LL; Calatzis AN; Feyh J; Hipp R; Hargasser SR
Acta Anaesthesiol Scand; 2000 Oct; 44(9):1116-21. PubMed ID: 11028733
[TBL] [Abstract][Full Text] [Related]
20. In vitro effects of different medium molecular hydroxyethyl starch solutions and lactated Ringer's solution on coagulation using SONOCLOT.
Konrad CJ; Markl TJ; Schuepfer GK; Schmeck J; Gerber HR
Anesth Analg; 2000 Feb; 90(2):274-9. PubMed ID: 10648306
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
